Announcement on Receipt of Court Pre-Reorganization Decision
Yan'an Bikon Pharmaceutical Co., Ltd. and all members of the board guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Special Reminder:
- On May 11, 2023, the 52nd meeting of the 5th Board of Directors of Yan'an Bikon Pharmaceutical Co., Ltd. approved the proposal to apply to the court for pre-reorganization to avoid further deterioration of the company's debt and operational risks. The details of the application for pre-reorganization were disclosed in the announcement on May 12, 2023 (Announcement No. 2023-083).
- On May 12, 2023, the company received the "Decision of the Intermediate People's Court of Yan'an, Shaanxi Province" (2023) Shaan 06 Po Shen No. 3, which agreed to accept the company's application for pre-reorganization. The court's decision to conduct pre-reorganization does not mean the company has formally entered the reorganization process. There remains significant uncertainty regarding whether the company can enter the reorganization process, and the company has not yet received any legal documents from the court regarding entering the reorganization process.
- The company has triggered conditions for delisting. Regardless of the success of this pre-reorganization, it does not affect the company's risk of delisting. Investors are advised to invest rationally and pay attention to investment risks.